ABSTRACT
INTRODUCTION: Syncope is the motivation for numerous diagnostic tests, among them transthoracic echocardiography (TTE); however, previous evidence suggests there is little utility in this test. Our objective was to assess its diagnostic yield in syncope, analysing the effect of age and sex. MATERIAL AND METHODS: We conducted an observational study that included patients with syncope and who underwent TTE between 1990 and 2015. We defined diagnostic findings related to syncope and performed a descriptive analysis, assessing the diagnostic yield (overall and according to age and sex). RESULTS: The study included 3302 patients and measured a diagnostic yield of 8.8%; the most common finding was ventricular dysfunction (4.5%). The probability of a diagnostic TTE significantly increased with age (p<.001) but was low for patients younger than 50 years (2.3%). The male sex was significantly related with a diagnostic TTE (p<.001), mostly due to the higher rate of ventricular dysfunction. CONCLUSIONS: The diagnostic yield of TTE in patients with syncope is moderate, low in patients younger than 50 years and lower in women than in men. These factors should be considered when conducting a diagnostic study of patients with syncope.
Subject(s)
Echocardiography , Syncope , Diagnostic Tests, Routine , Female , Humans , Male , Middle AgedABSTRACT
Introducción El síncope es motivo de numerosas pruebas diagnósticas, entre las que está el ecocardiograma transtorácico (ETT). Existe evidencia previa que sugiere escasa utilidad de esta prueba. Nuestro objetivo fue evaluar su rendimiento diagnóstico en el síncope, analizando el efecto de la edad y el sexo. Materiales y métodos Estudio observacional en el que se incluyeron pacientes con síncope y ETT entre 1990 y 2015. Se definieron hallazgos diagnósticos relacionados con el síncope. Realizamos un análisis descriptivo evaluando el rendimiento diagnóstico en global, y en función de edad y sexo. Resultados Se incluyeron 3.302 pacientes, siendo el rendimiento diagnóstico del 8,8%; el hallazgo más frecuente fue disfunción ventricular (4,5%). La probabilidad de ETT diagnóstico aumentó significativamente con la edad (p<0,001), siendo baja en menores de 50 años (2,3%). El sexo masculino se relacionó significativamente con ETT diagnóstico (p<0,001), a expensas de mayor frecuencia de disfunción ventricular. Conclusiones El rendimiento diagnóstico del ETT en pacientes con síncope es moderado, siendo bajo en edades inferiores a 50 años, y menor en mujeres que en hombres. Estos factores deben ser tenidos en cuenta a la hora del estudio diagnóstico de los pacientes con síncope (AU)
Introduction Syncope is the motivation for numerous diagnostic tests, among them transthoracic echocardiography (TTE); however, previous evidence suggests there is little utility in this test. Our objective was to assess its diagnostic yield in syncope, analysing the effect of age and sex. Material and methods We conducted an observational study that included patients with syncope and who underwent TTE between 1990-2015. We defined diagnostic findings related to syncope and performed a descriptive analysis, assessing the diagnostic yield (overall and according to age and sex). Results The study included 3,302 patients and measured a diagnostic yield of 8.8%; the most common finding was ventricular dysfunction (4.5%). The probability of a diagnostic TTE significantly increased with age (p<.001) but was low for patients younger than 50 years (2.3%). The male sex was significantly related with a diagnostic TTE (p<.001), mostly due to the higher rate of ventricular dysfunction. Conclusions The diagnostic yield of TTE in patients with syncope is moderate, low in patients younger than 50 years and lower in women than in men. These factors should be considered when conducting a diagnostic study of patients with syncope (AU)
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Echocardiography , Syncope/diagnosis , Reproducibility of Results , Retrospective Studies , Sex Factors , Age FactorsABSTRACT
INTRODUCTION: Therapy with cationic amphiphilic drugs (Amiodarone or hydroxychloroquine) may result in biochemically and ultrastructurally similar lipid inclusions in many cells also affected by Fabry disease (FD). In addition, it often results in similar clinical manifestations such as cornea verticillata. This may lead to a FD misdiagnosis, especially when a complete medical history is not available to the ophthalmologist confronted with cornea verticillata or to the pathologist examining a kidney biopsy. When enzymatic/genetic test or pathological studies are not conclusive, a specific biomarker may help clarify this dilemma. The plasma globotriaosylsphingosine (lyso-Gb3) assay has high sensitivity and specificity and is elevated above normal levels in FD. MATERIALS AND METHODS: We measured plasma lyso-Gb3 levels in male patients receiving Amiodarone or hydroxychloroquine and compared it with male patients with classic and late onset variant of FD. RESULTS: In all Fabry patients (classic and late onset variant) α-GalA activity was deficient in dried blood spot and plasma lyso-Gb3 was above normal levels. Patients on treatment with Amiodarone or hydroxychloroquine had normal values for α-GalA activity and lyso-Gb3 in plasma. CONCLUSIONS: Even when Amiodarone or hydroxychloroquine may decrease α-GalA activity in vitro or in cell culture, our results showed that in all patients lyso-Gb3 plasma levels remain normal with no evidence of reduction in α-GalA activity, confirming the specificity of this biomarker for the diagnosis of FD.
Subject(s)
Fabry Disease/blood , Glycolipids/blood , Sphingolipids/blood , Adult , Aged , Amiodarone/administration & dosage , Amiodarone/adverse effects , Fabry Disease/drug therapy , Humans , Hydroxychloroquine/administration & dosage , Hydroxychloroquine/adverse effects , Incidental Findings , Male , Middle AgedABSTRACT
INTRODUCTION: Syncope is the motivation for numerous diagnostic tests, among them transthoracic echocardiography (TTE); however, previous evidence suggests there is little utility in this test. Our objective was to assess its diagnostic yield in syncope, analysing the effect of age and sex. MATERIAL AND METHODS: We conducted an observational study that included patients with syncope and who underwent TTE between 1990-2015. We defined diagnostic findings related to syncope and performed a descriptive analysis, assessing the diagnostic yield (overall and according to age and sex). RESULTS: The study included 3,302 patients and measured a diagnostic yield of 8.8%; the most common finding was ventricular dysfunction (4.5%). The probability of a diagnostic TTE significantly increased with age (p<.001) but was low for patients younger than 50 years (2.3%). The male sex was significantly related with a diagnostic TTE (p<.001), mostly due to the higher rate of ventricular dysfunction. CONCLUSIONS: The diagnostic yield of TTE in patients with syncope is moderate, low in patients younger than 50 years and lower in women than in men. These factors should be considered when conducting a diagnostic study of patients with syncope.
